Welcome

IPM Biotech is a cutting-edge, science driven specialized bioanalytical contract research organization (CRO) dedicated to immune mediated diseases and disorders. The high degree of complexity of the mechanisms and consequences of novel treatment options require a broad knowledge in immunological interactions and medical understanding.

We develop assays to support drug developing companies in their drug development programs. These activities include small or mid-sized Biotech companies (SME) and large pharmaceutical companies as well as dedicated Biosimilar companies.  

This analytical portfolio comprises a wide range of assays for a sensitive and specific quantitation of biological drugs, a broad spectrum of assays for the determination of anti-drug antibodies (ADA) and assays for the measurement of PD biomarkers. Moreover, functional assays become more important for the determination of the mode of action of the drug, the assessment of functional cytotoxicity and the involvement of cellular immune response. All of these assays can easily be used for comparative purposes.

IPM Biotech combines novel technologies with scientific and medical expertise following an interdisciplinary approach. Our company’s size and flexibility allows for creativity, customization, and responsiveness to help improve efficiencies as well as project outcomes.

It is important to note that IPM Biotech works strictly in compliance with GLP regulations and is ISO certified according to DIN EN ISO 17025.